- Home
- OPRX vs HYI Comparison
OPRX vs HYI Comparison
Compare OPRX & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPRX | HYI |
|---|---|---|
| Founded | 2006 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.1M | 135.2M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | OPRX | HYI |
|---|---|---|
| Price | $5.12 | $10.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $16.67 | N/A |
| AVG Volume (30 Days) | ★ 367.1K | 68.9K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.59% |
| EPS Growth | ★ 124.55 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,429,000.00 | N/A |
| Revenue This Year | $3.88 | N/A |
| Revenue Next Year | $8.34 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 18.78 | N/A |
| 52 Week Low | $4.54 | $10.44 |
| 52 Week High | $22.25 | $12.12 |
Technical Indicators
Market Signals| Indicator | OPRX | HYI |
|---|---|---|
| Relative Strength Index (RSI) | 45.58 | 40.47 |
| Support Level | $4.92 | $10.51 |
| Resistance Level | $5.57 | $10.67 |
| Average True Range (ATR) | 0.27 | 0.05 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 44.95 | 36.41 |
Price Performance
Historical ComparisonAbout OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.